JP2019528271A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019528271A5 JP2019528271A5 JP2019508842A JP2019508842A JP2019528271A5 JP 2019528271 A5 JP2019528271 A5 JP 2019528271A5 JP 2019508842 A JP2019508842 A JP 2019508842A JP 2019508842 A JP2019508842 A JP 2019508842A JP 2019528271 A5 JP2019528271 A5 JP 2019528271A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- gene
- deletion
- smallpox
- chikungunya
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016903295A AU2016903295A0 (en) | 2016-08-19 | Viral Vaccines | |
| AU2016903295 | 2016-08-19 | ||
| PCT/AU2017/050879 WO2018032057A1 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019528271A JP2019528271A (ja) | 2019-10-10 |
| JP2019528271A5 true JP2019528271A5 (enExample) | 2020-05-14 |
Family
ID=61195904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508842A Pending JP2019528271A (ja) | 2016-08-19 | 2017-08-18 | ウイルスワクチン |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10905759B2 (enExample) |
| EP (2) | EP4331676A3 (enExample) |
| JP (1) | JP2019528271A (enExample) |
| KR (1) | KR20190050787A (enExample) |
| CN (1) | CN109862909A (enExample) |
| AR (1) | AR110624A1 (enExample) |
| AU (1) | AU2017313450B2 (enExample) |
| CA (2) | CA3034282A1 (enExample) |
| CL (1) | CL2019000405A1 (enExample) |
| IL (1) | IL264893B (enExample) |
| MA (1) | MA45994A (enExample) |
| MX (1) | MX2019001919A (enExample) |
| MY (1) | MY200887A (enExample) |
| NZ (1) | NZ750578A (enExample) |
| SG (1) | SG11201900814QA (enExample) |
| TW (1) | TWI728173B (enExample) |
| WO (1) | WO2018032057A1 (enExample) |
| ZA (1) | ZA201900641B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113347993A (zh) * | 2018-10-22 | 2021-09-03 | 艾赛澳克莱克斯疗法有限责任公司 | 突变牛痘病毒及其用途 |
| TW202203966A (zh) * | 2020-03-31 | 2022-02-01 | 澳大利亞商賽門蒂斯公司 | 用於防範ｃｏｖｉｄ－１９之以減毒的痘病毒載體為底質之疫苗 |
| CN112362877B (zh) * | 2020-10-27 | 2024-04-12 | 江苏先声医学诊断有限公司 | 一种mbp重组蛋白以及其应用 |
| KR102864666B1 (ko) * | 2025-04-21 | 2025-09-29 | 대한민국 | 치쿤구니아 바이러스 외피 재조합 dna를 포함하는 백신 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2243937T3 (es) * | 1994-04-29 | 2005-12-01 | Baxter Healthcare S.A. | Poxvirus recombinados en regiones esenciales con la ayuda de polinucleotidos extraños. |
| CN1418951A (zh) * | 2001-05-23 | 2003-05-21 | 广州绿健生物技术有限公司 | 生产rna病毒和基于rna病毒的载体颗粒的组合物及方法 |
| UA82479C2 (uk) * | 2002-05-16 | 2008-04-25 | Бавариан Нордика А/С | Міжгенні регіони як сайти вставки в геном модифікованого вірусу коров'ячої віспи ankara (mva) |
| WO2004014314A2 (en) * | 2002-08-12 | 2004-02-19 | David Kirn | Methods and compositions concerning poxviruses and cancer |
| KR20040015624A (ko) | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물 |
| EP1594970B1 (en) * | 2003-02-18 | 2008-07-30 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Recombinant mva and method for generation thereof |
| EP1518932A1 (en) * | 2003-09-29 | 2005-03-30 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Modified vaccinia virus Ankara (MVA) mutant and use thereof |
| EP1683870A1 (en) * | 2005-01-24 | 2006-07-26 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Vaccines based on the use of MVA |
| GB201006405D0 (en) * | 2010-04-16 | 2010-06-02 | Isis Innovation | Poxvirus expression system |
| AU2011305348A1 (en) | 2010-09-23 | 2013-04-18 | Baxter Healthcare Sa | Recombinant viral vectors and methods for inducing an immune response to yellow fever virus |
| EP2968528B1 (en) * | 2013-03-15 | 2022-02-23 | Sementis Limited | Immune modulation |
| US10544397B2 (en) * | 2013-11-01 | 2020-01-28 | Sementis Limited | Viral vector manufacture |
| WO2016086980A1 (en) * | 2014-12-02 | 2016-06-09 | Consejo Superior De Investigaciones Cientificas | Vaccine composition |
| US20190030157A1 (en) | 2016-02-03 | 2019-01-31 | Geovax Inc. | Compositions and Methods for Generating an Immune Response to a Flavivirus |
-
2017
- 2017-08-18 MY MYPI2019000845A patent/MY200887A/en unknown
- 2017-08-18 MA MA045994A patent/MA45994A/fr unknown
- 2017-08-18 NZ NZ750578A patent/NZ750578A/en unknown
- 2017-08-18 AR ARP170102311A patent/AR110624A1/es unknown
- 2017-08-18 CA CA3034282A patent/CA3034282A1/en active Pending
- 2017-08-18 KR KR1020197007662A patent/KR20190050787A/ko not_active Ceased
- 2017-08-18 IL IL264893A patent/IL264893B/en unknown
- 2017-08-18 JP JP2019508842A patent/JP2019528271A/ja active Pending
- 2017-08-18 US US16/325,539 patent/US10905759B2/en active Active
- 2017-08-18 AU AU2017313450A patent/AU2017313450B2/en active Active
- 2017-08-18 MX MX2019001919A patent/MX2019001919A/es unknown
- 2017-08-18 CA CA3265584A patent/CA3265584A1/en active Pending
- 2017-08-18 SG SG11201900814QA patent/SG11201900814QA/en unknown
- 2017-08-18 CN CN201780063830.0A patent/CN109862909A/zh active Pending
- 2017-08-18 EP EP23215911.1A patent/EP4331676A3/en active Pending
- 2017-08-18 TW TW106128111A patent/TWI728173B/zh not_active IP Right Cessation
- 2017-08-18 WO PCT/AU2017/050879 patent/WO2018032057A1/en not_active Ceased
- 2017-08-18 EP EP17840633.6A patent/EP3500280A4/en not_active Withdrawn
-
2019
- 2019-01-30 ZA ZA2019/00641A patent/ZA201900641B/en unknown
- 2019-02-14 CL CL2019000405A patent/CL2019000405A1/es unknown
-
2020
- 2020-12-22 US US17/130,165 patent/US20210113684A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6818797B2 (ja) | 強靭なｔ細胞用のｐｒ１３．５プロモータ及び抗体応答 | |
| CA2422094C (en) | Vaccination method | |
| Herbert et al. | Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR | |
| JP2016510989A5 (enExample) | ||
| Webster et al. | Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers | |
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| CA2408328A1 (en) | Immunogenic polypeptides encoded by mage minigenes and uses thereof | |
| JP4700907B2 (ja) | ウイルス増殖方法 | |
| Mendes et al. | Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1 | |
| JP2011041578A5 (enExample) | ||
| Weyer et al. | Poxvirus-vectored vaccines for rabies—a review | |
| EP2552490A4 (en) | INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF | |
| ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
| JP2022509221A5 (enExample) | ||
| JP2010523138A5 (enExample) | ||
| JP2016074727A5 (enExample) | ||
| JP2024105526A5 (enExample) | ||
| WO2008097267A2 (en) | Vaccines against vesicular stomatitis | |
| RU2015115785A (ru) | Мсн-специфичные пептиды со смещенной рамкой считывания (псрс) для предотвращения и лечения рака | |
| JP2023528984A (ja) | コロナウイルス病に対する組換え修飾ワクシニアウイルスアンカラ（ｍｖａ）ワクチン | |
| ZA201900641B (en) | Viral vaccines | |
| EA200701801A1 (ru) | Применение модифицированных поксвирусов для быстрой индукции иммунитета против поксвирусных или других инфекционных агентов | |
| Kyriakis | Tomorrow’s vector vaccines for small ruminants | |
| Meseda et al. | Percutaneous vaccination as an effective method of delivery of MVA and MVA-vectored vaccines | |
| JP2022547786A5 (enExample) |